Page last updated: 2024-08-17

aspartic acid and Mast-Cell Leukemia

aspartic acid has been researched along with Mast-Cell Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arber, DA; Berubé, C; Chen, CC; Cohen, PS; Coutré, SE; Durocher, JA; Galli, SJ; George, TI; Gilliland, DG; Gotlib, J; Growney, JD; Heinrich, MC; Kajiguchi, T; Lichy, JH; Lilleberg, SL; Neckers, L; Ruan, J; Wang, Y; Williams, C	1

Other Studies

1 other study(ies) available for aspartic acid and Mast-Cell Leukemia

Article	Year
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood, 2005, Oct-15, Volume: 106, Issue:8 Topics: Aspartic Acid; Cell Proliferation; Cells, Cultured; Female; Humans; Immunophenotyping; Leukemia, Mast-Cell; Middle Aged; Mutation; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Staurosporine	2005

Article

Year

Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation.

Blood, 2005, Oct-15, Volume: 106, Issue:8

Topics: Aspartic Acid; Cell Proliferation; Cells, Cultured; Female; Humans; Immunophenotyping; Leukemia, Mast-Cell; Middle Aged; Mutation; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-kit; Staurosporine

2005